In this study, we searched for novel regulators of CXCL9/10/11 expression and T-cell-inflamed GEP in CRC samples using the TCGA gene expression data and identified SPATA2 and CYLD as inhibitors of the aforementioned chemokines in tumor cells (Figure 1). This evidence concerns the gene CXCL9 and colorectal carcinoma.